{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:28:56Z","timestamp":1767907736861,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.contraception.2011.09.007","type":"journal-article","created":{"date-parts":[[2011,11,4]],"date-time":"2011-11-04T18:41:07Z","timestamp":1320432067000},"page":"402-407","source":"Crossref","is-referenced-by-count":20,"title":["Comparison of medical abortion follow-up with serum human chorionic gonadotropin testing and in-office assessment"],"prefix":"10.1016","volume":"85","author":[{"given":"Erin L.","family":"Horning","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice A.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie A.","family":"Meyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell D.","family":"Creinin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2011.09.007_bb0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1363\/4304111","article-title":"Abortion incidence and access to services in the United States, 2008","volume":"43","author":"Jones","year":"2011","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.contraception.2011.09.007_bb0010","unstructured":"Mifeprex package insert, Danco Laboratories, April 22, 2009."},{"key":"10.1016\/j.contraception.2011.09.007_bb0015","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/GRF.0b013e3181a2b026","article-title":"Medication abortion","volume":"52","author":"Bartz","year":"2009","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.09.007_bb0020","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.contraception.2007.01.021","article-title":"Clinical utility of urine pregnancy assays to determine medical abortion outcome is limited","volume":"75","author":"Godfrey","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.09.007_bb0025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.contraception.2009.08.008","article-title":"Feasibility of telephone follow-up after medical abortion","volume":"81","author":"Perriera","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.09.007_bb0030","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0301-2115(03)00012-5","article-title":"Verifying the effectiveness of medical abortion; ultrasound versus hCG testing","volume":"109","author":"Fiala","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2011.09.007_bb0040","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/00016340701203632","article-title":"Risk factors for unsuccessful medical abortion with mifepristone and misoprostol","volume":"86","author":"Haimov-Kochman","year":"2007","journal-title":"Acta Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.09.007_bb0045","doi-asserted-by":"crossref","unstructured":"Winikoff B. Acceptability of medical abortion. Fam Plann Perspec. 1995;27:142\u20138, 185.","DOI":"10.2307\/2136257"},{"key":"10.1016\/j.contraception.2011.09.007_bb0050","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1067\/mob.2000.107950","article-title":"Abortion with mifepristone and misoprostol: regimens, efficacy, acceptability, and future directions","volume":"183","author":"Newhall","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.09.007_bb0055","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1471-0528.2004.00153.x","article-title":"WHO multinational study of three misoprostol regimens after mifepristone for early medical abortions. II: side effects and women's perceptions","volume":"111","author":"Honkanen","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2011.09.007_bb0060","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/humrep\/deq037","article-title":"Home self-administration of vaginal misoprostol for medical abortion at 50\u201363 days compared with gestation of below 50 days","volume":"25","author":"Kallner","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2011.09.007_bb0065","first-page":"469","article-title":"Efficacy of mifepristone followed on the same day by misoprostol for early termination of pregnancy; report of a randomized trial","volume":"108","author":"Creinin","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.09.007_bb0070","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0010-7824(01)00228-1","article-title":"Mifepristone followed on the same day by vaginal misoprostol for early abortion","volume":"64","author":"Pymar","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.09.007_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-7824(98)00150-4","article-title":"Low-dose mifepristone 200 mg and vaginal misoprostol for abortion","volume":"59","author":"Schaff","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.09.007_bb0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0010-7824(99)00119-5","article-title":"Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days","volume":"61","author":"Schaff","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.09.007_bb0085","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0010-7824(02)00366-9","article-title":"Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy","volume":"66","author":"Schaff","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.09.007_bb0090","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJM199804303381801","article-title":"Early pregnancy termination with mifepristone and misoprostol in the United States","volume":"338","author":"Spitz","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2011.09.007_bb0095","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/01.AOG.0000258298.35143.d2","article-title":"Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion","volume":"109","author":"Creinin","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.09.007_bb0100","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1067\/mob.2003.131","article-title":"Mifepristone and misoprostol and methotrexate and misoprostol in clinical practice for abortion","volume":"188","author":"Creinin","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.09.007_bb0105","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.contraception.2004.04.005","article-title":"Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion","volume":"70","author":"Rossi","year":"2004","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411005269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411005269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T23:25:10Z","timestamp":1560900310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782411005269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0010782411005269"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2011.09.007","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}